Healthcare provider profile · identity verified

Kristina E Ray, MD

Allopathic & Osteopathic Physicians|Internal Medicine · WILMER, AL · NPI 1598831422

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Kristina E Ray, MD received $50.37 in general payments during 2025 across 2 reported records.

ABBVIE INC. accounted for 59.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Vraylar by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$50.37

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$29.96	59.5%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$20.41	40.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$50.37	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$29.96	1	2025
Source payment records 2025-08-20 · ABBVIE INC. · $29.96 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$29.96	1	2025
Source payment records 2025-08-20 · ABBVIE INC. · $29.96 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$20.41	1	2025
Source payment records 2025-05-14 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $20.41 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	41	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	24	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	16	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	716	127
Atorvastatin Calcium	Atorvastatin Calcium	698	188
Levothyroxine Sodium	Levothyroxine Sodium	472	119
Amlodipine Besylate	Amlodipine Besylate	416	113
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	379	74
Pantoprazole Sodium	Pantoprazole Sodium	355	98
Trazodone Hcl	Trazodone Hcl	347	98
Lisinopril	Lisinopril	295	75
Omeprazole	Omeprazole	271	78
Rosuvastatin Calcium	Rosuvastatin Calcium	256	72
Furosemide	Furosemide	244	68
Metoprolol Succinate	Metoprolol Succinate	237	64
Losartan Potassium	Losartan Potassium	236	65
Escitalopram Oxalate	Escitalopram Oxalate	235	58
Famotidine	Famotidine	225	58
Carvedilol	Carvedilol	209	58
Duloxetine Hcl	Duloxetine Hcl	208	58
Eliquis	Apixaban	198	41
Metformin Hcl Er	Metformin Hcl	198	55
Sertraline Hcl	Sertraline Hcl	198	47
Tizanidine Hcl	Tizanidine Hcl	188	53
Donepezil Hcl	Donepezil Hcl	187	40
Quetiapine Fumarate	Quetiapine Fumarate	178	37
Mounjaro	Tirzepatide	173	25
Albuterol Sulfate Hfa	Albuterol Sulfate	169	65
Fluoxetine Hcl	Fluoxetine Hcl	160	29
Buspirone Hcl	Buspirone Hcl	159	45
Metformin Hcl	Metformin Hcl	158	44
Potassium Chloride	Potassium Chloride	155	45
Farxiga	Dapagliflozin Propanediol	148	34
Ozempic	Semaglutide	148	35
Pregabalin	Pregabalin	144	24
Meloxicam	Meloxicam	143	38
Tramadol Hcl	Tramadol Hcl	138	33
Clopidogrel	Clopidogrel Bisulfate	130	36
Venlafaxine Hcl Er	Venlafaxine Hcl	125	32
Ezetimibe	Ezetimibe	122	37
Pravastatin Sodium	Pravastatin Sodium	121	39
Allopurinol	Allopurinol	114	27
Simvastatin	Simvastatin	111	38
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Montelukast Sodium	Montelukast Sodium	106	31
Memantine Hcl	Memantine Hcl	104	24
Mirtazapine	Mirtazapine	104	26
Metoprolol Tartrate	Metoprolol Tartrate	103	28
Tamsulosin Hcl	Tamsulosin Hcl	102	31
Jardiance	Empagliflozin	100	22
Esomeprazole Magnesium	Esomeprazole Magnesium	99	22
Lantus	Insulin Glargine,hum.Rec.Anlog	98	24
Bupropion Xl	Bupropion Hcl	97	29
Levetiracetam	Levetiracetam	96	23
Ondansetron Hcl	Ondansetron Hcl	96	42
Trulicity	Dulaglutide	89	14
Celecoxib	Celecoxib	86	23
Citalopram Hbr	Citalopram Hydrobromide	84	26
Diclofenac Sodium	Diclofenac Sodium	80	30
Alendronate Sodium	Alendronate Sodium	76	22
Fluticasone Propionate	Fluticasone Propionate	75	29
Ropinirole Hcl	Ropinirole Hcl	70	15
Baclofen	Baclofen	69	15
Alprazolam	Alprazolam	67	13
Fluconazole	Fluconazole	67	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	16
Zolpidem Tartrate	Zolpidem Tartrate	66	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	22
Paroxetine Hcl	Paroxetine Hcl	61	13
Aripiprazole	Aripiprazole	60	12
Bisoprolol Fumarate	Bisoprolol Fumarate	60	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	21
Hydralazine Hcl	Hydralazine Hcl	59	20
Olanzapine	Olanzapine	59	13
Spironolactone	Spironolactone	58	17
Tresiba Flextouch U-200	Insulin Degludec	57	11
Xarelto	Rivaroxaban	56	suppressed
Atenolol	Atenolol	54	17
Januvia	Sitagliptin Phosphate	54	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	17
Prednisone	Prednisone	50	34
Sucralfate	Sucralfate	50	14
Clonazepam	Clonazepam	49	13
Rybelsus	Semaglutide	49	13
Acetaminophen-Codeine	Acetaminophen With Codeine	48	suppressed
Ibuprofen	Ibuprofen	47	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	12
Lorazepam	Lorazepam	47	21
Tresiba Flextouch U-100	Insulin Degludec	47	11
Cephalexin	Cephalexin	46	35
Levemir Flexpen	Insulin Detemir	45	suppressed
Valsartan	Valsartan	45	12
Topiramate	Topiramate	44	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Linzess	Linaclotide	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	12
Lamotrigine	Lamotrigine	40	suppressed
Cefdinir	Cefdinir	38	33
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	28
Methenamine Hippurate	Methenamine Hippurate	38	suppressed
Methocarbamol	Methocarbamol	38	12
Nystatin	Nystatin	38	28
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	11
Midodrine Hcl	Midodrine Hcl	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	11
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	33	suppressed
Hydrocortisone	Hydrocortisone	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	14
Humalog	Insulin Lispro	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	27
Valacyclovir	Valacyclovir Hcl	32	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	25
Torsemide	Torsemide	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	24
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Premarin	Estrogens, Conjugated	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Azithromycin	Azithromycin	27	23
Estradiol	Estradiol	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Ondansetron Odt	Ondansetron	25	17
Risperidone	Risperidone	25	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	suppressed
Kerendia	Finerenone	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Trintellix	Vortioxetine Hydrobromide	23	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Roflumilast	Roflumilast	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	15
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Rizatriptan	Rizatriptan Benzoate	21	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	suppressed
Colchicine	Colchicine	20	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Lactulose	Lactulose	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Mupirocin	Mupirocin	19	16
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Amoxicillin	Amoxicillin	18	11
Bupropion Hcl	Bupropion Hcl	18	suppressed
Carbamazepine	Carbamazepine	18	suppressed
Colesevelam Hcl	Colesevelam Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Lacosamide	Lacosamide	18	suppressed
Nyamyc	Nystatin	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Rexulti	Brexpiprazole	18	suppressed
Brilinta	Ticagrelor	17	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Insulin Lispro	Insulin Lispro	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Vilazodone Hcl	Vilazodone Hcl	17	suppressed
Ceftriaxone	Ceftriaxone Sodium	16	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Prolia	Denosumab	16	suppressed
Temazepam	Temazepam	16	suppressed
Vraylar	Cariprazine Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	12
Dapagliflozin	Dapagliflozin Propanediol	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Methimazole	Methimazole	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Levofloxacin	Levofloxacin	14	13
Megestrol Acetate	Megestrol Acetate	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Glipizide	Glipizide	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Digoxin	Digoxin	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Emgality Pen	Galcanezumab-Gnlm	11	suppressed
Emgality Syringe	Galcanezumab-Gnlm	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$50.37 · 2 records	ABBVIE INC.	CAPLYTA, QULIPTA, UBRELVY	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error